First Tracks Biotherapeutics, Inc. (TRAX)
Healthcare
Biotechnology
—
44.00 $
-7.8%
vs. previous close
Closing price · As of: 31. Jul 2026
First Tracks Biotherapeutics, Inc. (TRAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q1 25 | Q1 26 |
|---|---|---|
| -45 | -33 | |
| 0.6 | 0.1 | |
| 7.7 | 12 | |
| -4.5 | 6.3 | |
| 0.0 | 0.0 | |
| 15 | 35 | |
| 5.7 | 7.9 | |
| -24 | 10 | |
| -45 | -33 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.